The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. [Conference abstract]

Metadata

Item Type: Conference abstract
Authors/Creators:
  • Reed, M.
  • Cairns, D.A. ORCID logo https://orcid.org/0000-0002-2338-0179
  • Pawlyn, C.
  • Davies, F.E.
  • Sigsworth, R.
  • Brioli, A.
  • Jenner, M.W.
  • Kaiser, M.F.
  • Olivier, C.
  • Owen, R.
  • Boyd, K.
  • Cook, G.
  • Morgan, G.J.
  • Jackson, G.
  • Drayson, M.
  • Jones, J.R.
Copyright, Publisher and Additional Information:

© 2023 by The American Society of Hematology. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 2 November 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
A25447
Celgene Corporation
RV-MM-PI-0251
Merck Sharp & Dohme Ltd
MERCK - MYELOMA XI
Date Deposited: 11 Jun 2024 10:17
Last Modified: 05 Mar 2026 14:35
Status: Published
Publisher: American Society of Hematology
Identification Number: 10.1182/blood-2023-181939
Open Archives Initiative ID (OAI ID):

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)